Envestnet Asset Management’s CapForce IBD 50 ETF FFTY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q1
Sell
-5,745
Closed -$236K 3531
2020
Q4
$236K Sell
5,745
-9,373
-62% -$366K ﹤0.01% 3052
2020
Q3
$564K Sell
15,118
-2,917
-16% -$108K ﹤0.01% 2386
2020
Q2
$621K Sell
18,035
-6,101
-25% -$190K ﹤0.01% 2275
2020
Q1
$676K Sell
24,136
-154
-0.6% -$5.13K ﹤0.01% 2044
2019
Q4
$844K Buy
24,290
+8,069
+50% +$273K ﹤0.01% 2135
2019
Q3
$523K Buy
16,221
+941
+6% +$32.2K ﹤0.01% 2341
2019
Q2
$524K Buy
15,280
+6,466
+73% +$218K ﹤0.01% 2376
2019
Q1
$295K Buy
8,814
+896
+11% +$28.2K ﹤0.01% 2605
2018
Q4
$219K Buy
+7,918
New +$246K ﹤0.01% 2636

Other funds holding FFTY

Envestnet Asset Management's FFTY Position: Q1 2021 in Review

Envestnet Asset Management sold out of CapForce IBD 50 ETF (FFTY) in Q1 2021, closing a stake of 5,745 shares — an estimated $236K sold.

Envestnet Asset Management first reported a position in FFTY in Q4 2018 and held it in 9 quarters. The position peaked at $844K in Q4 2019. 68 funds tracked by Wall St. Rank hold FFTY as of Q1 2021.

  • Envestnet Asset Management reported no remaining CapForce IBD 50 ETF position as of Q1 2021 after selling out during the quarter.
  • Envestnet Asset Management sold 5,745 CapForce IBD 50 ETF shares in Q1 2021, an estimated $236K.
  • Envestnet Asset Management first reported a position in CapForce IBD 50 ETF in Q4 2018 and held it in 9 quarters.
  • Envestnet Asset Management's CapForce IBD 50 ETF position peaked at $844K in Q4 2019.
  • 68 funds tracked by Wall St. Rank held CapForce IBD 50 ETF as of Q1 2021.

Based on Envestnet Asset Management's 13F filing for Q1 2021, filed 4 May 2021.